These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34302814)

  • 1. Modulation of the tumor microenvironment (TME) by melatonin.
    Mu Q; Najafi M
    Eur J Pharmacol; 2021 Sep; 907():174365. PubMed ID: 34302814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products.
    Lafta HA; AbdulHussein AH; Al-Shalah SAJ; Alnassar YS; Mohammed NM; Akram SM; Qasim MT; Najafi M
    Curr Top Med Chem; 2023; 23(12):1104-1122. PubMed ID: 36722486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of the tumor microenvironment by curcumin.
    Fu X; He Y; Li M; Huang Z; Najafi M
    Biofactors; 2021 Nov; 47(6):914-932. PubMed ID: 34375483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of the tumor immune microenvironment by metformin.
    Wu Z; Zhang C; Najafi M
    J Cell Commun Signal; 2022 Sep; 16(3):333-348. PubMed ID: 34611852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells.
    Mu Q; Najafi M
    Int Immunopharmacol; 2021 Sep; 98():107895. PubMed ID: 34171623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting Anti-tumour Immunity Using Adjuvant Apigenin.
    Huang J; Chen X; Chang Z; Xiao C; Najafi M
    Anticancer Agents Med Chem; 2023; 23(3):266-277. PubMed ID: 35616683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin blunts the tumor-promoting effect of cancer-associated fibroblasts by reducing IL-8 expression and reversing epithelial-mesenchymal transition.
    Liao H; Li H; Dong J; Song J; Chen H; Si H; Wang J; Bai X
    Int Immunopharmacol; 2023 Jun; 119():110194. PubMed ID: 37080066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boosting immune system against cancer by melatonin: A mechanistic viewpoint.
    Mortezaee K; Potes Y; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M; Farhood B
    Life Sci; 2019 Dec; 238():116960. PubMed ID: 31629760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interactions of docetaxel with tumor microenvironment.
    Gupta R; Kadhim MM; Turki Jalil A; Qasim Alasheqi M; Alsaikhan F; Khalimovna Mukhamedova N; Alexis Ramírez-Coronel A; Hassan Jawhar Z; Ramaiah P; Najafi M
    Int Immunopharmacol; 2023 Jun; 119():110214. PubMed ID: 37126985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
    Jarboe T; Tuli NY; Chakraborty S; Maniyar RR; DeSouza N; Xiu-Min Li ; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():1-31. PubMed ID: 34888842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Multifunction Role of Tumor-Associated Mesenchymal Stem Cells and Their Interaction with Immune Cells in Breast Cancer.
    Chauhan A; Agarwal S; Masih M; Gautam PK
    Immunol Invest; 2023 Nov; 52(7):856-878. PubMed ID: 37615117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles.
    Ten A; Kumeiko V; Farniev V; Gao H; Shevtsov M
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Emerging Model for Cancer Development from a Tumor Microenvironment Perspective in Mice and Humans.
    Yamaguchi R; Perkins G
    Adv Exp Med Biol; 2020; 1225():19-29. PubMed ID: 32030645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.